Add like
Add dislike
Add to saved papers

Treatment strategies for fibrous dysplasia.

In fibrous dysplasia (FD), growth of the lesions usually arrests around early adolescence. However, in some cases, it continues even after this period, and it is not clear under what kind of conditions this growth continues. If this continued growth could be predicted, it would provide a vital assessment tool to determine when bone contouring should be performed. We were able to find numerous reports about FD concerning surgical procedures, but only a small number included long-term postoperative follow-up. In this paper, we investigated 11 patients with FD who were available for a postoperative follow-up longer than a 10-year period. Of these 11 patients, 6 were male and 5 were female, and the mean initial assessment age was 17.9 years. Three cases were diagnosed as Albright syndrome, 3 as monostotic, and 5 as polyostotic. Regrowth after the operation occurred in 9 of the 11 patients. Among these, growth was arrested in 5 patients at the average age of 23 years, and growth is still being observed in the remaining 4 patients including 3 patients with Albright syndrome. No statistically significant difference was detected between the affected bones and the age of growth arrest, mean age of growth arrest, and sex. Consequently, we believe it is best to perform bone contouring subsequent to growth arrest other than Albright syndrome. When growth continues indefinitely in patients with the polyostotic type, as with Albright syndrome, recurrence of the disease and the resultant deformities are predicted, so complete resection and reconstructive surgery is recommended.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app